Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Agilent Technologies Inc. | 15 | 4 | 1 | 0 | €125.30 | €133.39 | 6.453% |
| Tenet Healthcare | 40 | 0 | 8 | 0 | €140.00 | €141.72 | 1.231% |
| Neurocrine Bioscience | 35 | 0 | 4 | 0 | €134.75 | €143.34 | 6.378% |
| Novo Nordisk A/S ADR | 20 | 1 | 1 | 0 | €116.00 | €144.02 | 24.154% |
| Quest Diagnostics Inc. | 7 | 0 | 1 | 0 | €133.00 | €145.02 | 9.036% |
| Merck KGaA | 3 | 2 | 0 | 1 | €157.55 | €146.00 | -7.331% |
| Masimo Corp. | 7 | 1 | 0 | 0 | €98.68 | €147.62 | 49.591% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €125.00 | €150.00 | 20.000% |
| Universal Health Services B | 11 | 6 | 2 | 3 | €195.00 | €162.45 | -16.693% |
| Illumina Inc. | 27 | 4 | 5 | 0 | €108.64 | €162.53 | 49.605% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €144.40 | €165.00 | 14.266% |
| AbbVie Inc. | 31 | 0 | 7 | 0 | €167.66 | €176.90 | 5.511% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €124.45 | €182.96 | 47.015% |
| Jazz Pharmaceuticals plc | 27 | 0 | 1 | 0 | €100.75 | €184.92 | 83.543% |
| Krystal Biotech | 17 | 0 | 0 | 0 | €196.25 | €186.59 | -4.922% |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Johnson & Johnson | 39 | 1 | 4 | 0 | €147.08 | €195.31 | 32.789% |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | €167.74 | €200.06 | 19.266% |
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €208.10 | €204.50 | -1.730% |
| Resmed Inc. | 19 | 0 | 0 | 0 | €189.65 | €207.72 | 9.526% |
| Insulet Corp. | 17 | 0 | 0 | 0 | €189.25 | €216.46 | 14.378% |
| Laboratory Corp. Of America (labcorp) | 12 | 0 | 1 | 0 | €197.00 | €237.94 | 20.782% |
| BeiGene Ltd ADR | 9 | 1 | 0 | 0 | €151.00 | €241.54 | 59.963% |
| Teleflex Inc. | 10 | 0 | 1 | 0 | €204.00 | €244.75 | 19.977% |
| Charles River Labs Intl | 12 | 0 | 1 | 0 | €204.60 | €248.57 | 21.491% |